image-20200706-3953-9g2twc

Dr Nicole Lee

Professor at the National Drug Research Institute (Melbourne), Curtin University
Nicole Lee is Adjunct Professor at the National Drug Research Institute (NDRI), Curtin University. She is also CEO and Managing Director at Hello Sunday Morning and CEO at 360Edge, a specialist alcohol and other drugs consultancy translating research to policy and practice, as well as a consultant psychologist in practice. She has worked in the alcohol and other drugs and mental health sectors for 34 years as a clinician and teaching and research academic.Her area of expertise is in alcohol and other drug policy and practice, especially methamphetamine/’ice’; cannabis policy; alcohol use and treatment; and general harm reduction and treatment approaches. She has extensive clinical and treatment expertise in these areasNicole is a member of the Australian National Advisory Council on Alcohol and Drugs (ANACAD), a member of the Board of The Loop Australia, and Fellow of the Australian Association for Cognitive and Behaviour Therapy. She has previously served on the boards of the Australasian Professional Society on Alcohol and other Drugs (APSAD); the Australian Association for Cognitive and Behaviour Therapy; and the Alcohol and other Drugs Council of Australia (ADCA).

More from this expert

Relying on intention and willpower to stop drinking, even for a short period, is not usually enough. So what are the best strategies to take a break from drinking?

Clinical Articles iconClinical Articles

Anecdotal reports from some professionals have prompted concerns about young people using prescription benzodiazepines such as Xanax for recreational use.

Clinical Articles iconClinical Articles

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.